Stay updated on CaboNivoIpi in Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the CaboNivoIpi in Thyroid Cancer Clinical Trial page.

Latest updates to the CaboNivoIpi in Thyroid Cancer Clinical Trial page
- Check3 days agoChange DetectedThe study record now shows newer submission and posting dates (November 11 and 13, 2026) in place of the previous July 30 and 31, 2026 dates.SummaryDifference0.1%

- Check10 days agoChange DetectedThe study page displays the ClinicalTrials.gov record for a phase II trial of cabozantinib, nivolumab, and ipilimumab for advanced differentiated thyroid cancer, including eligibility, treatment, outcomes, and locations. It also includes posted results-related information and study documents.SummaryDifference98%

- Check17 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2; the page remains a 403 error.SummaryDifference0.2%

- Check31 days agoChange DetectedA sitewide NIH notice about using “Super Intelligence” in place of “Artificial Intelligence” appeared, and the site revision advanced from v3.7.1 to v3.7.2. The study page still displays a 403 error.SummaryDifference1%

- Check38 days agoChange DetectedThe footer revision identifier was updated from v3.7.0 to v3.7.1, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check52 days agoChange DetectedThe study page currently displays a 403 Forbidden error, indicating the study record is inaccessible; the content area has been replaced with a standard error page while site chrome remains, preventing access to the study details.SummaryDifference22%

Stay in the know with updates to CaboNivoIpi in Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CaboNivoIpi in Thyroid Cancer Clinical Trial page.